Magnetic nanoparticle hyperthermia enhancement of cisplatin chemotherapy cancer treatment.
Magnetic nanoparticle hyperthermia enhancement of cisplatin chemotherapy cancer treatment.
复制标题
DOI:
10.3109/02656736.2013.825014
复制
发表时间:
2013-12
期刊:
影响因子:
--
通讯作者:
Hoopes PJ
中科院分区:
文献类型:
--
作者:
Petryk AA;Giustini AJ;Gottesman RE;Kaufman PA;Hoopes PJ
The purpose of this study was to examine the therapeutic effect of magnetic nanoparticle hyperthermia (mNPH) combined with systemic cisplatin chemotherapy in a murine mammary adenocarcinoma model (MTGB). An alternating magnetic field (35.8 kA/m at 165 kHz) was used to activate 110 nm hydroxyethyl starch-coated magnetic nanoparticles (mNP) to a thermal dose of 60 min at 43 °C. Intratumoral mNP were delivered at 7.5 mg of Fe/cm3 of tumour (four equal tumour quadrants). Intraperitoneal cisplatin at 5 mg/kg body weight was administered 1 h prior to mNPH. Tumour regrowth delay time was used to assess the treatment efficacy. mNP hyperthermia, combined with cisplatin, was 1.7 times more effective than mNP hyperthermia alone and 1.4 times more effective than cisplatin alone (p<0.05). Our results demonstrate that mNP hyperthermia can result in a safe and significant therapeutic enhancement for cisplatin cancer therapy.